Richard Scolyer, BMedSci, MBBS, MD, FRCPA, FRCPath, FAHMS

Professor
Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney,, United States

Presentation(s):

• P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?

  Thursday, March 23, 2023
  3:41 PM – 3:46 PM

  Disclosure information not submitted.

• P44: A Tool For Predicting The Risk Of Death From Melanoma And Competing Causes At Varying Time Intervals After Diagnosis

  Thursday, March 23, 2023
  3:51 PM – 3:56 PM

  Disclosure information not submitted.

• 56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram

  Friday, March 24, 2023
  10:14 AM – 10:24 AM

  Disclosure information not submitted.

• P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas

  Friday, March 24, 2023
  3:36 PM – 3:41 PM

  Disclosure information not submitted.